Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more
Market Cap & Net Worth: Indegene Ltd (INDGN)
Indegene Ltd (NSE:INDGN) has a market capitalization of $1.20 Billion (₹103.76 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #10295 globally and #424 in its home market, demonstrating a -4.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indegene Ltd's stock price ₹431.75 by its total outstanding shares 240317117 (240.32 Million).
Indegene Ltd Market Cap History: 2024 to 2026
Indegene Ltd's market capitalization history from 2024 to 2026. Data shows change from $1.68 Billion to $1.20 Billion (-14.06% CAGR).
Index Memberships
Indegene Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$1.27 Trillion | 0.04% | #352 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.65 Billion | 0.26% | #137 of 250 |
Weight: Indegene Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Indegene Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Indegene Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Indegene Ltd's market cap is 0.05 times its annual revenue
1.54x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.36x
Indegene Ltd's market cap is 0.36 times its annual earnings
252.98x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.68 Billion | $25.90 Billion | $3.37 Billion | 0.06x | 0.50x |
| 2025 | $1.44 Billion | $28.39 Billion | $4.07 Billion | 0.05x | 0.36x |
Competitor Companies of INDGN by Market Capitalization
Companies near Indegene Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Indegene Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Indegene Ltd Historical Marketcap From 2024 to 2026
Between 2024 and today, Indegene Ltd's market cap moved from $1.68 Billion to $ 1.20 Billion, with a yearly change of -14.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹1.20 Billion | -17.04% |
| 2025 | ₹1.44 Billion | -13.79% |
| 2024 | ₹1.68 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Indegene Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.20 Billion USD |
| MoneyControl | $1.20 Billion USD |
| MarketWatch | $1.20 Billion USD |
| marketcap.company | $1.20 Billion USD |
| Reuters | $1.20 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.